跳至主要内容
临床试验/NCT02267681
NCT02267681已完成4 期

The Effects of Fentanyl and Alfentanil as an Adjunct to Propofol on Cognitive Functions for Sedation in Colonoscopy

Perihan Ekmekçi1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
cognitive dysfunction

研究概览

简要总结

This study aims to compare the effects of fentanyl and alfentanil on postprocedural cognitive function in elective endoscopy.

150 patients will be enrolled in the study. Patients meeting eligibility criteria will be randomly allocated to three groups.

The patients in Group A will be given propofol and alfentanil. The patients in Group F will be given propofol and fentanyl. Group P is designated as the control group and the patients will be given propofol for sedation.

Awareness, vital signs and pain will be evaluated. Side effects will be recorded. Patient and endoscopist satisfaction will be evaluated.

详细描述

In this study we aimed to compare the effects of sedation provided by propofol with the addition of the short-acting opioid alfentanil and long-acting opioid fentanyl on cognitive functions, pain, side effects during the procedure and the endoscopist and patient satisfaction.

Following the approval of Kırıkkale University ethics committee, 150 patients ages between 18 and 65 ASA I-III scheduled for elective endoscopy and colonoscopy will be enrolled in the study.

After obtaining written informed consent, APAIS (The Amsterdam Preoperative Anxiety and Information Scale) and MMTS (Mini Mental Test Scoring) tests will given to patients. Following TDT (Trieger Dot Test) and DSST (Digit Symbol Substitution Test), the patients will be randomly allocated to either Propofol-Alfentanil (Group A), Propofol-Fentanyl (Group F) or Propofol-Control (Group P) which consists of 50 patients each.

The patients in Group A will be given 100 mcg/kg/min propofol infusion and 10 mcg/kg loading dose of alfentanil and 5 mcg/kg additional bolus of alfentanil whenever FPS (Faces Pain Scale) is greater than 3 or the patients can not tolerate the procedure.

The patients in Group F will be given 100 mcg/kg/min propofol infusion and 1 mcg/kg loading dose of fentanyl and 5 mcg/kg additional bolus of fentanyl whenever FPS (Faces Pain Scale) is greater than 3 or the patients could not tolerate the procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ages between 18-65
  • American Society of Anesthesiologists classification I-III
  • Patients scheduled to undergo elective colonoscopy or endoscopy and colonoscopy

排除标准

  • Patients younger than 18 or older than 65
  • Mini mental test score < 26
  • APAIS (The Amsterdam Preoperative Anxiety and Information Scale) >10
  • Serious systemic disease
  • Neuropsychiatric disorder
  • Chronic alcohol abuse
  • Morbid obesity
  • History of anesthesia in the last 7 days
  • Known allergy to study drugs

研究组 & 干预措施

Group A

Experimental

The patients in Group A will be given 100 mcg/kg/min propofol infusion and 10 mcg/kg loading dose of alfentanil and 5 mcg/kg additional bolus of alfentanil whenever FPS (Faces Pain Scale) is greater than 3 or the patients can not tolerate the procedure.

干预措施: Alfentanil (Drug)

Group A

Experimental

The patients in Group A will be given 100 mcg/kg/min propofol infusion and 10 mcg/kg loading dose of alfentanil and 5 mcg/kg additional bolus of alfentanil whenever FPS (Faces Pain Scale) is greater than 3 or the patients can not tolerate the procedure.

干预措施: Propofol (Drug)

Group F

Experimental

The patients in Group F will be given 100 mcg/kg/min propofol infusion and 1 mcg/kg loading dose of fentanyl and 5 mcg/kg additional bolus of fentanyl whenever FPS (Faces Pain Scale) is greater than 3 or the patients can not tolerate the procedure.

干预措施: Fentanyl (Drug)

Group F

Experimental

The patients in Group F will be given 100 mcg/kg/min propofol infusion and 1 mcg/kg loading dose of fentanyl and 5 mcg/kg additional bolus of fentanyl whenever FPS (Faces Pain Scale) is greater than 3 or the patients can not tolerate the procedure.

干预措施: Propofol (Drug)

Group P

Active Comparator

Group P is designated as the control group and the patients will be given 100mcg/kg/min infusion and sedation will be achieved via 1 mg/kg propofol loading dose and 0.5 mg/kg propofol additional bolus will be given whenever the patients can not tolerate the procedure or FPS is greater than 3.

干预措施: Propofol (Drug)

结局指标

主要结局

cognitive dysfunction

时间窗: during the 30 minutes after the termination of the procedure

as evaluated using Trieger dot test,Mini mental test and Digit symbol substitution test

次要结局

  • Patient and endoscopist satisfaction(following the procedure)
  • Pain(during the 30 minutes after the termination of the procedure)
  • Side effects(during the 30 minutes after the termination of the procedure)

研究者

发起方
Perihan Ekmekçi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Perihan Ekmekçi

Assistant Professor

Ufuk University

研究点 (1)

Loading locations...

相似试验